Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$12.0MFederal grants as PI7 awards
0Patents grantedNone matched
79Papers1,901 citations
Federal awards and patents by year
AwardsPatents
7 awards · $12.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 19, 2026 | NIH | SBIR Phase II Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy | $1000K | Linnaeus Therapeutics LLC |
| Jan 13, 2025 | NIH | SBIR Phase II Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy | $1000K | Linnaeus Therapeutics LLC |
| Mar 30, 2023 | NIH | SBIR Phase II Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma | $2.0M | Linnaeus Therapeutics LLC |
| Apr 5, 2022 | NIH | SBIR Phase II Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma | $2.0M | Linnaeus Therapeutics LLC |
| Apr 5, 2022 | NIH | SBIR Phase II Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma | $4.0M | Linnaeus Therapeutics LLC |
| Feb 11, 2020 | NIH | SBIR Phase II Development of GPER Agonists as Cancer Therapeutics | $1.0M | Linnaeus Therapeutics LLC |
| Feb 21, 2019 | NIH | SBIR Phase II Development of GPER Agonists as Cancer Therapeutics | $1.0M | Linnaeus Therapeutics LLC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#41
Awards as PI#250
Patents#273
Companies
- Linnaeus Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.